How Much Does Avodart (Dutasteride) Cost in California in 2026?

Brand vs. Generic Pricing in California

The price gap between brand-name Avodart and generic dutasteride is among the widest in the 5-alpha reductase inhibitor class. GSK's list price for brand Avodart remains near $290 per month in 2026, while generic dutasteride averages roughly $25 per month at California retail pharmacies. This pricing pattern mirrors the broader post-patent field documented after generic entry in 2015 [1].

Why Generics Dropped So Far

Dutasteride's patent expiration opened the market to multiple manufacturers. The FDA Orange Book lists several AB-rated generic formulations, meaning they meet bioequivalence standards against the reference listed drug. California pharmacies can substitute generics automatically under state law unless a prescriber writes "dispense as written."

Retail Pharmacy Price Variation

Cash prices vary by location. Costco and large chain pharmacies in metro areas like Los Angeles, San Francisco, and San Diego tend to price generic dutasteride between $15 and $35 for a 30-day supply. Independent pharmacies may charge $30 to $50. Checking multiple pharmacies or using a discount card before filling is a practical step [2].

The FDA-approved prescribing information for Avodart specifies the standard dose: one 0.5 mg soft gelatin capsule taken once daily, with or without food [3]. There is no dose titration required, which simplifies cost forecasting. One capsule per day for 30 days means your monthly out-of-pocket cost is predictable.

California Medi-Cal Coverage for Dutasteride

Medi-Cal, California's Medicaid program, covers dutasteride with prior authorization. The prior authorization requirement typically means your prescriber must document a diagnosis of benign prostatic hyperplasia (BPH) and, in some cases, demonstrate that first-line alpha-blocker therapy was tried or is inappropriate [4].

How to Get Prior Authorization Approved

A successful PA submission usually includes the patient's International Prostate Symptom Score (IPSS) documentation, prostate volume or PSA level, and a clinical rationale for dual 5-alpha reductase inhibition rather than alpha-blocker monotherapy. The CombAT trial (N=4,844) demonstrated that combination therapy with dutasteride and tamsulosin reduced BPH clinical progression by 41.3% compared with tamsulosin alone at 4 years, which provides strong clinical justification for PA requests [5].

Medi-Cal Managed Care Plans

Most Medi-Cal enrollees are in managed care plans (e.g., LA Care, Health Net, Molina). Formulary placement and PA criteria vary by plan. Some managed care formularies prefer finasteride as a first-step therapy because of its lower cost, requiring a trial or documented intolerance before approving dutasteride [6]. Your prescriber's office can check real-time formulary status through the plan's pharmacy portal.

Compounded Dutasteride in California

Compounded dutasteride is available through licensed 503A compounding pharmacies in California. The California State Board of Pharmacy regulates these facilities under both state law and the federal Drug Quality and Security Act (DQSA) framework established by the FDA [7].

Legal Status and Oversight

Under Section 503A of the Federal Food, Drug, and Cosmetic Act, a pharmacy can compound dutasteride for an individual patient based on a valid prescription. This is fully legal in California. The drug is not on the FDA's "difficult to compound" list, and dutasteride does not appear on the current FDA withdrawn or removed list [8].

Cost and Use Cases

Compounded dutasteride costs approximately $40 per month from California 503A pharmacies. Compounding is most commonly used for topical dutasteride formulations applied directly to the scalp for androgenetic alopecia (male pattern hair loss), an off-label use. Eun et al. (2010) reported in the Journal of the American Academy of Dermatology that dutasteride 0.5 mg daily produced significantly greater hair count increases than finasteride 1 mg at 24 weeks in a randomized trial of 416 men with androgenetic alopecia [9].

Topical compounded formulations aim to reduce systemic exposure while maintaining local follicular effect, though large randomized trials of topical dutasteride are still limited. A 2022 systematic review found topical 5-alpha reductase inhibitors showed promise for hair loss with potentially fewer systemic side effects, but called for more rigorous comparative data [10].

Insurance Coverage Beyond Medi-Cal

Commercial insurance plans in California generally cover generic dutasteride for BPH. Brand Avodart is rarely covered at a preferred tier since generic equivalents are available.

Major Carriers

Plans from Kaiser Permanente, Blue Shield of California, Anthem Blue Cross, and Health Net typically place generic dutasteride on Tier 1 or Tier 2 formularies for BPH. Copays range from $0 to $20 per month depending on the plan. The American Urological Association (AUA) guidelines support 5-alpha reductase inhibitors as a standard treatment for moderate-to-severe BPH with prostate enlargement, which aligns coverage decisions with evidence-based care [11].

Covered California Marketplace Plans

Covered California marketplace plans must cover prescription drugs as an essential health benefit under the Affordable Care Act. Generic dutasteride is included in the formularies of most Silver, Gold, and Platinum tier plans. Bronze plans cover it too but often carry higher copays or deductibles.

Off-Label Hair Loss Coverage

Insurance almost never covers dutasteride for hair loss. The FDA-approved indication is BPH only [3]. Off-label prescribing is legal and common, but insurers classify hair loss treatment as cosmetic. Patients using dutasteride for androgenetic alopecia should expect to pay cash price. The Endocrine Society does not list dutasteride in its clinical practice guidelines for androgen-related conditions as a first-line hair loss therapy, which further limits insurance justification [12].

Discount Programs and Savings Strategies

Several pathways exist to reduce dutasteride costs in California below even the average $25 generic cash price.

Manufacturer Savings Cards

GSK offers savings programs for brand Avodart. Eligibility is restricted to commercially insured patients. These cards do not apply to government insurance (Medi-Cal, Medicare, TRICARE). Savings vary but can reduce brand copays to $30 to $50 per month for qualifying patients.

Pharmacy Discount Programs

GoodRx, RxSaver, and similar platforms frequently list generic dutasteride at $8 to $15 for a 30-count supply at California pharmacies including CVS, Walgreens, Rite Aid, and Costco. These discount cards are free to use and accepted at most pharmacies statewide. They are not insurance and cannot be combined with insurance copays.

90-Day Fills and Mail Order

Filling a 90-day supply instead of 30-day reduces per-unit cost at many pharmacies. Mail-order services through insurers (e.g., Kaiser mail-order, Express Scripts, Optum Rx) often price 90-day generic dutasteride at $10 to $25 total, which works out to $3 to $8 per month [13].

Patient Assistance Programs

NeedyMeds and RxAssist maintain databases of patient assistance programs for prescription drugs. Generic dutasteride is inexpensive enough that most manufacturer-sponsored assistance programs target brand Avodart. Patients without insurance earning below 200% of the federal poverty level may qualify through GSK's patient assistance program or state-run pharmaceutical assistance [14].

Telehealth Prescribing in California

California permits dutasteride prescribing via telehealth with no in-person visit requirement for initial consultation. This is legal under the California Business and Professions Code, and the state's telehealth parity laws mandate that insurers cover telehealth visits at the same rate as in-person visits.

How Telehealth Works for Dutasteride

A licensed California prescriber (physician, NP, or PA) conducts a synchronous video or audio visit, reviews symptoms and medical history, and can prescribe dutasteride electronically. For BPH, the prescriber may order a PSA test and urinalysis before prescribing. The AUA recommends baseline PSA measurement before starting 5-alpha reductase inhibitors because these drugs reduce PSA by approximately 50% within 6 months, which affects prostate cancer screening interpretation [15].

Monitoring Requirements

The FDA label recommends that patients on dutasteride have periodic PSA monitoring and that clinicians adjust the measured PSA value (doubling the reported number) when screening for prostate cancer [3]. Follow-up telehealth visits every 6 to 12 months are standard practice. Lab work can be completed at any California draw site.

Clinical Efficacy: What You Get for the Cost

Cost matters most in the context of clinical benefit. Dutasteride has strong evidence for its primary approved indication.

BPH Outcomes

The REDUCE trial (N=6,729) demonstrated that dutasteride 0.5 mg daily reduced the relative risk of biopsy-detectable prostate cancer by 22.8% over 4 years compared with placebo (p<0.001), while also reducing BPH-related symptoms and acute urinary retention risk [16]. The CombAT study showed mean IPSS improvements of 6.2 points with combination therapy versus 4.9 points with tamsulosin alone at 48 months [5].

Hair Loss Outcomes

For androgenetic alopecia, the phase III Korean trial by Eun et al. found dutasteride 0.5 mg increased target area hair count by 12.2 hairs/cm² more than finasteride 1 mg at 24 weeks (p<0.05) [9]. A larger phase III trial by Gubelin Harcha et al. (2014) (N=917) confirmed dutasteride 0.5 mg superiority over finasteride 1 mg for hair count change at 24 weeks across multiple doses [17].

Safety Profile

Common side effects include decreased libido (1.3%), erectile dysfunction (1.3%), and ejaculation disorders (0.5%), per the FDA prescribing information [3]. These rates come from placebo-controlled BPH trials. The Endocrine Society notes that sexual side effects are typically reversible upon discontinuation [12]. Dutasteride is contraindicated in pregnancy and women of childbearing potential because of the risk of fetal abnormalities. The drug's long half-life (approximately 5 weeks) means it persists in serum well after discontinuation [3].

How California Compares to Other States

California's average cash price of $25 per month for generic dutasteride sits near the national median. States with fewer retail pharmacies or lower generic penetration may see prices $5 to $15 higher. California benefits from high pharmacy competition in urban areas and strong Medi-Cal generic substitution policies.

State-Specific Factors

California's Board of Pharmacy actively licenses and inspects 503A compounding facilities, which maintains a competitive compounding market. The state's large Covered California exchange creates broad formulary access. California law (SB 17, 2017) requires pharmaceutical companies to provide advance notice of list price increases above certain thresholds, adding pricing transparency not present in every state [18].